BCM
VYGR icon

Bridgeway Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Bridgeway Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Hold
87,459
– – 0.01% 974
2026
Q1 		$338K Hold
87,459
– – 0.01% 904
2025
Q4 		$344K Hold
87,459
– – 0.01% 896
2025
Q3 		$408K Sell
87,459
-25,000
-22% -$90.4K 0.01% 847
2025
Q2 		$350K Sell
112,459
-48,200
-30% -$155K 0.01% 835
2025
Q1 		$543K Buy
160,659
+110,553
+221% +$516K 0.01% 733
2024
Q4 		$284K Sell
50,106
-135,003
-73% -$870K 0.01% 934
2024
Q3 		$1.08M Buy
185,109
+2,278
+1% +$16.6K 0.02% 663
2024
Q2 		$1.45M Buy
182,831
+3,060
+2% +$25.7K 0.03% 590
2024
Q1 		$1.67M Sell
179,771
-1,025
-0.6% -$8.65K 0.03% 623
2023
Q4 		$1.53M Buy
+180,796
New +$1.31M 0.03% 661
2023
Q2 		– Sell
-101,781
Closed -$785K – 1452
2023
Q1 		$785K Hold
101,781
– – 0.02% 780
2022
Q4 		$621K Hold
101,781
– – 0.02% 844
2022
Q3 		$603K Buy
101,781
+15,000
+17% +$96K 0.02% 850
2022
Q2 		$513K Hold
86,781
– – 0.01% 870
2022
Q1 		$661K Buy
86,781
+50,000
+136% +$223K 0.01% 873
2021
Q4 		$100K Sell
36,781
-145,100
-80% -$495K ﹤0.01% 1222
2021
Q3 		$478K Buy
181,881
+25,581
+16% +$83.1K 0.01% 1045
2021
Q2 		$646K Sell
156,300
-108,039
-41% -$490K 0.01% 994
2021
Q1 		$1.25M Buy
+264,339
New +$1.8M 0.02% 792
2018
Q4 		– Sell
-35,000
Closed -$662K – 1464
2018
Q3 		$662K Sell
35,000
-35,000
-50% -$672K 0.01% 1062
2018
Q2 		$1.37M Hold
70,000
– – 0.01% 754
2018
Q1 		$1.31M Hold
70,000
– – 0.01% 741
2017
Q4 		$1.16M Hold
70,000
– – 0.01% 790
2017
Q3 		$1.44M Buy
+70,000
New +$790K 0.02% 705

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bridgeway Capital Management's VYGR Position: Q2 2026 in Review

Bridgeway Capital Management held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 87,459 shares worth $306K. The position accounts for 0.01% of the portfolio, ranked #974.

Bridgeway Capital Management first reported a position in VYGR in Q3 2017 and has held it in 25 quarters since. The position peaked at $1.67M in Q1 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Bridgeway Capital Management held 87,459 shares of Voyager Therapeutics worth $306K as of Q2 2026.
  • Bridgeway Capital Management left its Voyager Therapeutics share count unchanged in Q2 2026.
  • Voyager Therapeutics made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #974 holding.
  • Bridgeway Capital Management first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 25 quarters since.
  • Bridgeway Capital Management's Voyager Therapeutics position peaked at $1.67M in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.